uPAR-specific CAR T cells effectively ablated senescent cells both in vitro and in vivo, and reduced liver fibrosis induced by carbon tetrachloride (CCl4) or nonalcoholic steatohepatitis (NASH) resulting in an improvement of liver functions. Here, PLAUR is linked to metabolic dysfunction-associated steatohepatitis.